Calise Chris
SEC insider (Form 3/4/5 filer). CIK 0001824769. Director at Coeptis Therapeutics Holdings, Inc. (COEP). 3 reported Form 4/5 transactions since Sep 2024; latest on Feb 11, 2026. Located in WEXFORD, PA.
Companies Calise Chris has filed insider reports for
- Coeptis Therapeutics Holdings, Inc. (COEP): Director
Calise Chris
CIK: 0001824769
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)1 (33.3%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
COEP
Coeptis Therapeutics Holdings, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Feb 11, 2026COEP
Coeptis Therapeutics Holdings, Inc.
ExerciseDirect5.7K shares at avg. $10.56$60K - Feb 11, 2026COEP
Coeptis Therapeutics Holdings, Inc.
AwardDirect3.3K shares- - Mar 4, 2025COEP
Coeptis Therapeutics Holdings, Inc.
AwardDirectNon-qualified Stock Options (right to buy)
5.7K shares-
1-3 of 3 transactions